Jacob Gross
Vividion Therapeutics (United States)
ORCID: 0000-0002-4245-1155Also affiliated with National Cancer Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Camille Tlemsani, Fathi Elloumi, Yasuhiro Arakawa, Ukhyun Jo, Jacob Gross +12 more
Papers
Driven by 7 papers — median percentile 72. Top paper: “Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation”.
Camille Tlemsani, Fathi Elloumi, Yasuhiro Arakawa, Ukhyun Jo, Jacob Gross +12 more
Jenny F. Nathans, Haiqing Fu, Christophe E. Redon, Lisa M. Jenkins, Bhushan Thakur +8 more
Christophe E. Redon, Koichi Utani, Bhushan Thakur, Sang‐Min Jang, Anna B. Marks +8 more
Jacob Gross, Roberto Vera Alvarez, Junko Murai, Sang‐Min Jang, Hongliang Zhang +10 more
Christophe E. Redon, Bhushan Thakur, Koichi Utani, Robin Sebastian, Sang‐Min Jang +11 more
Adrian Baris, Haiqing Fu, Christophe E. Redon, Lőrinc Sándor Pongor, Sara Mosavarpour +8 more
Jacob Gross, Roberto Vera Alvarez, Junko Murai, Sang‐Min Jang, Hongliang Zhang +10 more